Questions About Cancer? 1-800-4-CANCER

Cancer Drug Information

  • Posted: 10/05/2006
  • Updated: 10/26/2011

Paclitaxel Albumin-stabilized Nanoparticle Formulation

listen 1  (PA-klih-TAK-sil al-BYOO-min-STAY-bih-lized NA-noh-PAR-tih-kul for-myoo-LAY-shun)

This page contains brief information about paclitaxel albumin-stabilized nanoparticle formulation and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s): Abraxane
FDA Approved: Yes

FDA Approval for Paclitaxel Albumin-stabilized Nanoparticle Formulation 2

Use in Cancer

Paclitaxel Albumin-stabilized Nanoparticle Formulation is approved to treat:

The drug is also called nanoparticle paclitaxel and protein-bound paclitaxel. Nanoparticle paclitaxel causes fewer side effects than paclitaxel.

Nanoparticle paclitaxel is also being studied in the treatment of other types of cancer.

More About Paclitaxel Albumin-stabilized Nanoparticle Formulation

Definition from the NCI Drug Dictionary 3 - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Paclitaxel 4 - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Clinical Trials Accepting Patients

Find Clinical Trials for Paclitaxel Albumin-stabilized Nanoparticle Formulation 5 - Check for trials from NCI's list of cancer clinical trials now accepting patients.

Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.


Back to TopBack to Top



Glossary Terms

breast cancer (brest KAN-ser)
Cancer that forms in tissues of the breast, usually the ducts (tubes that carry milk to the nipple) and lobules (glands that make milk). It occurs in both men and women, although male breast cancer is rare.
cancer (KAN-ser)
A term for diseases in which abnormal cells divide without control and can invade nearby tissues. Cancer cells can also spread to other parts of the body through the blood and lymph systems. There are several main types of cancer. Carcinoma is a cancer that begins in the skin or in tissues that line or cover internal organs. Sarcoma is a cancer that begins in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue. Leukemia is a cancer that starts in blood-forming tissue such as the bone marrow, and causes large numbers of abnormal blood cells to be produced and enter the blood. Lymphoma and multiple myeloma are cancers that begin in the cells of the immune system. Central nervous system cancers are cancers that begin in the tissues of the brain and spinal cord. Also called malignancy.
drug (drug)
Any substance, other than food, that is used to prevent, diagnose, treat or relieve symptoms of a disease or abnormal condition. Also refers to a substance that alters mood or body function, or that can be habit-forming or addictive, especially a narcotic.
metastasize (meh-TAS-tuh-size)
To spread from one part of the body to another. When cancer cells metastasize and form secondary tumors, the cells in the metastatic tumor are like those in the original (primary) tumor.
recurrent cancer (ree-KER-ent KAN-ser)
Cancer that has recurred (come back), usually after a period of time during which the cancer could not be detected. The cancer may come back to the same place as the original (primary) tumor or to another place in the body. Also called recurrence.

Table of Links

1http://www.cancer.gov/PublishedContent/Media/CDR/Media/718690.mp3
2http://www.cancer.gov/cancertopics/druginfo/fda-nanoparticle-paclitaxel
3http://www.cancer.gov/Templates/drugdictionary.aspx?CdrID=38690
4http://www.nlm.nih.gov/medlineplus/druginfo/meds/a607070.html
5http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=38690&idtype=1
6http://www.cancer.gov/cancertopics/druginfo/alphalist
7http://www.cancer.gov/cancertopics/druginfo/drug-page-index
8http://www.cancer.gov/clinicaltrials/learningabout/approval-process-for-cancer-
drugs
9http://www.cancer.gov/cancertopics/factsheet/Therapy/investigational-drug-access